Wednesday, May 15, 2019 6:03:32 PM
Preliminary results of PROCLAIM-CX-072.
http://www.abstract.asco.org/239/AbstView_239_258869.html
Recent CTMX News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:41:03 PM
- CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 (EGFRxCD3 PROBODY® T-Cell Engager) • GlobeNewswire Inc. • 05/08/2024 08:10:00 PM
- CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/08/2024 08:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:04:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:01:21 PM
- CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with KEYTRUDA® (pembrolizumab) • GlobeNewswire Inc. • 05/07/2024 08:15:00 PM
- CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clinical Data Update on May 8, 2024 • GlobeNewswire Inc. • 05/01/2024 12:00:00 PM
- CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated EpCAM-Directed ADC, in a Phase 1 Study in Patients with Advanced Solid Tumors • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors • GlobeNewswire Inc. • 03/21/2024 12:00:00 PM
- CytomX Therapeutics Announces Milestone Achievement in PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas • GlobeNewswire Inc. • 03/18/2024 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/11/2024 08:30:38 PM
- CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/11/2024 08:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:02:08 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/11/2024 08:00:31 PM
- U.S. Index Futures Dip Ahead of Inflation Data and Oracle’s Earnings; Oil Prices Edge Higher • IH Market News • 03/11/2024 10:39:47 AM
- CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024 • GlobeNewswire Inc. • 03/04/2024 01:00:00 PM
- CytomX Therapeutics to Present at Upcoming March Investor Conferences • GlobeNewswire Inc. • 02/27/2024 01:00:00 PM
- CytomX Therapeutics Announces FDA Clearance of IND Applications for CX-2051, a Probody® Antibody Drug Conjugate (ADC) Targeting EpCAM and CX-801, a Conditionally Activated Interferon Alpha-2b • GlobeNewswire Inc. • 01/24/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2024 01:44:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2024 01:41:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2024 01:40:22 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2024 01:38:49 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2024 01:37:27 AM
- CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Conference • GlobeNewswire Inc. • 01/12/2024 01:00:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM